TrueWealth Advisors LLC lowered its stake in shares of Globe Life Inc. (NYSE:GL – Free Report) by 3.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,706 shares of the company’s stock after selling 435 shares during the period. TrueWealth Advisors LLC’s holdings in Globe Life were worth $1,417,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in GL. Merit Financial Group LLC purchased a new stake in shares of Globe Life in the 4th quarter valued at approximately $487,000. Kathmere Capital Management LLC purchased a new position in Globe Life in the fourth quarter worth approximately $217,000. Harbour Capital Advisors LLC acquired a new stake in Globe Life during the fourth quarter worth $244,000. Wealth Enhancement Advisory Services LLC increased its stake in Globe Life by 0.7% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 19,923 shares of the company’s stock worth $2,110,000 after acquiring an additional 144 shares during the last quarter. Finally, Diversified Trust Co purchased a new stake in Globe Life in the fourth quarter valued at $356,000. 81.61% of the stock is currently owned by hedge funds and other institutional investors.
Globe Life Trading Up 1.0 %
Shares of NYSE:GL opened at $118.47 on Friday. The company has a market cap of $9.94 billion, a PE ratio of 10.02 and a beta of 0.80. The company’s 50 day moving average is $109.90 and its two-hundred day moving average is $103.11. Globe Life Inc. has a 52 week low of $38.95 and a 52 week high of $132.00. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50.
Globe Life Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Monday, January 6th will be paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 0.81%. The ex-dividend date is Monday, January 6th. Globe Life’s payout ratio is 8.12%.
Insider Buying and Selling
In related news, Director Mark A. Blinn sold 3,000 shares of Globe Life stock in a transaction on Monday, January 6th. The shares were sold at an average price of $113.23, for a total transaction of $339,690.00. Following the sale, the director now directly owns 5,122 shares in the company, valued at $579,964.06. This trade represents a 36.94 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Frank M. Svoboda sold 13,448 shares of the company’s stock in a transaction on Monday, January 6th. The shares were sold at an average price of $112.56, for a total transaction of $1,513,706.88. Following the completion of the transaction, the chief executive officer now owns 18,948 shares of the company’s stock, valued at $2,132,786.88. This represents a 41.51 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 39,788 shares of company stock worth $4,429,779 over the last 90 days. 1.51% of the stock is owned by insiders.
Wall Street Analyst Weigh In
GL has been the subject of a number of recent analyst reports. Raymond James raised their price objective on Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a research report on Tuesday, October 15th. Truist Financial lifted their price target on shares of Globe Life from $90.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, October 25th. Keefe, Bruyette & Woods upped their price objective on shares of Globe Life from $135.00 to $137.00 and gave the stock an “outperform” rating in a report on Friday, January 10th. Piper Sandler lifted their target price on shares of Globe Life from $118.00 to $130.00 and gave the company an “overweight” rating in a report on Friday, October 25th. Finally, Evercore ISI upgraded Globe Life from an “in-line” rating to an “outperform” rating and upped their price target for the stock from $132.00 to $143.00 in a research note on Wednesday, January 8th. Four investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Globe Life presently has an average rating of “Moderate Buy” and an average target price of $134.00.
View Our Latest Analysis on GL
Globe Life Company Profile
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Read More
- Five stocks we like better than Globe Life
- P/E Ratio Calculation: How to Assess Stocks
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- How to Choose Top Rated Stocks
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Ride Out The Recession With These Dividend Kings
- MarketBeat Week in Review – 01/13 – 01/17
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.